Imperva Inc (NASDAQ:IMPV) has been given an average rating of “Hold” by the twenty brokerages that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $53.23.
Several equities analysts have recently issued reports on the stock. BidaskClub raised shares of Imperva from a “hold” rating to a “buy” rating in a report on Tuesday. Zacks Investment Research downgraded shares of Imperva from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 11th. DA Davidson assumed coverage on shares of Imperva in a report on Tuesday, April 10th. They set a “buy” rating and a $56.00 price target for the company. ValuEngine downgraded shares of Imperva from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Finally, Imperial Capital boosted their price target on shares of Imperva from $50.00 to $55.00 and gave the company an “outperform” rating in a report on Friday, February 9th.
In other Imperva news, Director Anthony J. Bettencourt sold 66,037 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total value of $3,102,418.26. Following the sale, the director now directly owns 66,037 shares in the company, valued at $3,102,418.26. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CRO Michael D. Mooney sold 24,454 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the completion of the sale, the executive now owns 24,454 shares in the company, valued at $1,153,739.72. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.
Shares of IMPV traded up $0.35 during midday trading on Wednesday, hitting $47.65. 330,895 shares of the stock traded hands, compared to its average volume of 391,469. Imperva has a 1-year low of $37.17 and a 1-year high of $52.40. The company has a market cap of $1,646.33, a price-to-earnings ratio of -170.18, a price-to-earnings-growth ratio of 54.06 and a beta of 1.67.
Imperva (NASDAQ:IMPV) last announced its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.13. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. The company had revenue of $91.10 million during the quarter, compared to the consensus estimate of $91.11 million. During the same quarter in the previous year, the company posted $0.32 earnings per share. The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. equities analysts expect that Imperva will post 0.03 EPS for the current fiscal year.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.